V
70
-6
FITB
53
-5
HBI
52
-3
USB
61
-4
LNC
36
-4
KMX
66
2
ES
19
-9
PEP
48
-5
PG
53
-8
ADT
40
-3
PYPL
50
-6
HPQ
53
-3
ORCL
54
3
TXN
43
-3
ADM
33
-4
MCD
59
5
AMT
45
2
CPB
30
-9
CL
58
-4
BRK.B
38
-5
V
70
-6
FITB
53
-5
HBI
52
-3
USB
61
-4
LNC
36
-4
KMX
66
2
ES
19
-9
PEP
48
-5
PG
53
-8
ADT
40
-3
PYPL
50
-6
HPQ
53
-3
ORCL
54
3
TXN
43
-3
ADM
33
-4
MCD
59
5
AMT
45
2
CPB
30
-9
CL
58
-4
BRK.B
38
-5
Financhill
Back

Korro Bio Stock Predictions

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

KRRO
Korro Bio

Last Price:
38.57
Seasonality Move:
9.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Korro Bio Stock Forecast

  • Over the next 52 weeks, Korro Bio has on average historically fallen by 22.1% based on the past 5 years of stock performance.
  • Korro Bio has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Korro Bio Stock Undervalued?
    The current Korro Bio [KRRO] share price is $47.51. The Score for KRRO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • KRRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Korro Bio Stock Go Up Next Year?

  • Over the next 52 weeks, Korro Bio has on average historically fallen by 22.1% based on the past 5 years of stock performance.

Korro Bio Stock Rating

Sell
37
Korro Bio (KRRO) is a Sell

Is Korro Bio overpriced?

  • Korro Bio has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Korro Bio Stock Price History

Is KRRO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRRO is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
korrobio.com

52-Week Data

52-Week High:
98.00
52-Week Low:
30.01

Prediction Charts

Market Cap:
445.09M
Price in USD:
47.51
Volume:
91.96K
Beta:
2.02

Technical Analysis

SMA50:
52.68
SMA100:
47.95
SMA200:
51.44
52-Wk Change:
-3.04%

Stock Predictions

  • Is Korro Bio stock public?
    Yes, Korro Bio is a publicly traded company.
  • What is the Korro Bio stock quote today?
    The Korro Bio stock price is 47.51 USD today.
  • How to buy Korro Bio stock online?
    You can buy Korro Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 65.98 55.01 70.49 52.89
Nov-14 54.01 49.70 57.94 49.20
Nov-15 49.70 47.56 49.90 46.19
Nov-18 49.86 46.63 51.30 46.47
Nov-19 45.75 46.63 48.19 44.65
Nov-20 46.78 47.00 49.46 45.30
Nov-21 48.12 50.62 51.50 47.41
Nov-22 52.00 52.31 56.00 51.50
Nov-25 51.75 52.00 53.21 48.92
Nov-26 51.62 53.25 56.69 48.71
Nov-27 54.34 54.99 55.21 50.92
Nov-29 55.11 52.06 56.04 51.89
Dec-2 52.69 53.50 55.39 49.77
Dec-3 51.89 47.51 53.06 47.35

Korro Bio Earnings

Korro Bio Earnings Report: Per Share Korro Bio Earnings Q1 Q2 Q3 and Q4 last year and next year.

Korro Bio Forecast Revenue Growth

Korro Bio Stock Analysis: Historical quarterly revenues per share for Korro Bio and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.97 per share, and a decrease next year of $0.52 per share.

* Korro Bio stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.